Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Selleck Chemical LLC Tafamidis meglumine E4852-100MG
Supplier: Selleck Chemical LLC E4852100MG
Tafamidis meglumine (Vyndaqel Fx-1006A) stabilizes the tetrameric structure of transthyretin (TTR) by binding to thyroxine-binding sites Tafamidis meglumine treats transthyretin familial amyloid polyneuropathies (TTR-FAP) a condition characterized by neurological damage from TTR amyloidosis by preventing the misfolding and aggregation of transthyretin (TTR) into amyloid fibrils
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?